Saudi Arabia Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook
Saudi Arabia clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)
Related Markets
Saudi Arabia clinical trial biorepository & archiving solutions market highlights
- The Saudi Arabia clinical trial biorepository & archiving solutions market generated a revenue of USD 7.6 million in 2023 and is expected to reach USD 15.3 million by 2030.
- The Saudi Arabia market is expected to grow at a CAGR of 10.5% from 2024 to 2030.
- In terms of segment, biorepository services was the largest revenue generating service in 2023.
- Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.
Clinical trial biorepository & archiving solutions market data book summary
| Market revenue in 2023 | USD 7.6 million |
| Market revenue in 2030 | USD 15.3 million |
| Growth rate | 10.5% (CAGR from 2023 to 2030) |
| Largest segment | Biorepository services |
| Fastest growing segment | Biorepository Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biorepository Services, Archiving Solution Services |
| Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.2% of the global clinical trial biorepository & archiving solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa clinical trial biorepository & archiving solutions market is projected to lead the regional market in terms of revenue in 2030.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 15.3 million by 2030.
Biorepository services was the largest segment with a revenue share of 65.79% in 2024. Horizon Databook has segmented the Saudi Arabia clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Availability of low-cost clinical resources, presence of qualified investigators, and ease in patient recruitment are some of the major factors boosting growth of clinical trial biorepository & archiving solutions market in the country.
Advancements in technology, rise in disease prevalence, and quicker regulatory approval as compared to countries such as China, India, and Brazil are some of the factors expected to further fuel growth of clinical trial biorepository & archiving solutions market in the region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Biorepository & Archiving Solutions Market Scope
Clinical Trial Biorepository & Archiving Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia clinical trial biorepository & archiving solutions market size, by service, 2018-2030 (US$M)
Saudi Arabia Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
